According to National Institute for Health and Care Excellence, patients with NT-proBNP, one of the main clinical diagnostic biomarkers of HF, levels above 2000 ng/L are suspected for HF and need echocardiographic examination [21]. This evidence concerns the gene NPPB and hydrops fetalis.